Corbus Pharmaceuticals Holdings earnings were -$84.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CRBP earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$23.0M, up 11.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CRBP reported annual earnings of -$78.5M, with 95.3% growth. The next CRBP earnings date is Aug 4, 2026.
Corbus Pharmaceuticals Holdings Earnings Reports & History FAQ
What were Corbus Pharmaceuticals Holdings's earnings last quarter?
Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) reported Q1 2026 earnings per share (EPS) of -$1.23, up 11.51% year over year. Total CRBP earnings for the quarter were -$22.97 million. In the same quarter last year, Corbus Pharmaceuticals Holdings's earnings per share (EPS) was -$1.39.
When does Corbus Pharmaceuticals Holdings report earnings?
The next CRBP earnings date is Aug 4, 2026. Add CRBP to your watchlist to be reminded of Corbus Pharmaceuticals Holdings's next earnings date.
Is Corbus Pharmaceuticals Holdings profitable or losing money?
As of the last Corbus Pharmaceuticals Holdings earnings report, Corbus Pharmaceuticals Holdings is currently losing money. Corbus Pharmaceuticals Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$84.53 million, a 68.09% increase year over year.
What was CRBP's earnings growth in the past year?
As of Corbus Pharmaceuticals Holdings's earnings date in Q3 2026, Corbus Pharmaceuticals Holdings's earnings has grown year over year. CRBP earnings in the past year totalled -$84.53 million.
What are Corbus Pharmaceuticals Holdings's earnings expectations?
The current EPS estimate for Corbus Pharmaceuticals Holdings's earnings report in Aug 4, 2026 is -$1.30.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.